MDM2 and neoplasm: Importantly, the double KD of β-catenin and MDM2 almost entirely blocked SP141’s anti-pancreatic cancer activity, indicating that the dual inhibition of β-catenin and MDM2 by this compound might exhibit a synergistic activity against tumor growth.